RAPT Therapeutics, Inc. Stock Forecast
RAPT Therapeutics, Inc. stock upgraded to Buy Candidate.
(Updated on May 03, 2024)
The RAPT Therapeutics, Inc. stock price gained 2.52% on the last trading day (Friday, 3rd May 2024), rising from $8.13 to $8.33. During the last trading day the stock fluctuated 5.28% from a day low at $8.15 to a day high of $8.58. The price has fallen in 6 of the last 10 days but is still up by 4.78% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 42 thousand more shares were traded than the day before. In total, 418 thousand shares were bought and sold for approximately $3.49 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RAPT Signals & Forecast
The RAPT Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $8.02 and $8.32. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, February 20, 2024, and so far it has risen 21.25%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for RAPT Therapeutics, Inc. stock
RAPT Therapeutics, Inc. finds support from accumulated volume at $8.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.430 between high and low, or 5.28%. For the last week, the stock has had daily average volatility of 6.15%.
Our recommended stop-loss: $7.99 (-4.08%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 52 days ago.)
Trading Expectations (RAPT) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect RAPT Therapeutics, Inc. to open at $8.35, and during the day (based on 14 day Average True Range), to move between $7.79 and $8.87, which gives a possible trading interval of +/-$0.540 (+/-6.48%) up or down from last closing price. If RAPT Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.96% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $8.47 (1.68%) than the support at $8.10 (2.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
RAPT Therapeutics, Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.780. We will update the financials statements for RAPT Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.87% in the first trading day after earnings release.
Is RAPT Therapeutics, Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 1.278 Buy Candidate Upgraded
Predicted Opening Price for RAPT Therapeutics, Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $8.35 ( 0.280%) | $8.33 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RAPT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 8.78 | 5.44 % | |
| R2 | 8.62 | 3.47 % | ||
| R1 | 8.52 | 2.25 % | ||
| Current price: | 8.33 | |||
| Support | S1 | 8.19 | -1.69 % | |
| S2 | 8.09 | -2.91 % | ||
| S3 | 7.92 | -4.88 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 10.18 | 22.21 % | |
| R2 | 9.24 | 10.92 % | ||
| R1 | 8.47 | 1.68 % | ||
| Current price | 8.33 | |||
| Support | S1 | 8.10 | -2.76% | |
| S2 | 7.90 | -5.16% | ||
| S3 | 6.87 | -17.53% |
FAQ
Click here for our free guide on how to buy RAPT Therapeutics, Inc. Stock.
